Volume 26, Number 8—August 2020
Dispatch
Leishmania donovani Infection with Atypical Cutaneous Manifestations, Himachal Pradesh, India, 2014–2018
Table 1
Standard Leishmania strains (place of origin) | WHO code | Genbank accession no. | Zymodeme | Disease form | Strain type† | ITS1 polymorphic microsatellite stretches (nucleotide position, bp) |
|||
---|---|---|---|---|---|---|---|---|---|
Poly C (24–39) | Poly A (24–39) | Poly TA (61–76) | Poly A (124–134) | ||||||
VL- and CL-causing L. infantum and L. donovani parasite strains | |||||||||
L. infantum (Tunisia) | MHOM/TN/80/IPT1 | AJ000289 | MON-1 | VL | A | 3 | 6 | 4 | 8 |
L. donovani (India) | MHOM/IN/00/DEVI | AJ634376 | MON-2 | VL | H | 2 | 8 | 5 | 7 |
L. donovani (Sri Lanka) | MHOM/LK/2002/ L60c | AM901447 | MON-37 | CL | ND | 2 | 8 | 5 | 7 |
L. donovani (Bangladesh) | ND | KT921417 | ND | VL | ND | 2 | 8 | 5 | 7 |
L. donovani (Kenya) | MHOM/KE/85/ NLB323 | AJ000297 | MON-37 | VL | G | 2 | 8 | 5 | 7 |
L. donovani (Sudan) | MHOM/SD/75/ LV139 | AJ000291 | ND | CL | E | 2 | 8 | 6 | 8 |
MHOM/SD/93/9S | AJ634372 | MON-18 | VL | F | 2 | 9 | 5 | 7 | |
L. donovani (Ethiopia) | MHOM/ET/67/HU3 | AJ634373 | MON-18 | VL | F | 2 | 9 | 5 | 7 |
L. donovani (China) | MHOM/CN/00/ Wangjie1 | AJ000294 | MON-35 | VL | C | 3 | 6 | 4 | 7 |
L. donovani (HP, India) | MHOM/IN/83/ CHANDIGARH | AM901449 | MON-37 | VL | ND | 2 | 8 | 2, TAA, 3 | 7 |
L. donovani (Bhutan) |
Trashigang1 | JQ730001 | ND | VL | ND | 2 | 8 | 2, TAA, 3 | 8 |
Samtse1 |
JQ730002 |
ND |
VL |
ND |
2 |
9 |
2, TAA, 3 |
8 |
|
CL-causing L. donovani isolates from Himachal Pradesh‡ | |||||||||
HPCL22 | – | MG982955 | ND | CL | ND | Heterogeneous | 2, TAA, 3 | 8 | |
HPCL27 | – | MG982958 | ND | CL | ND | Heterogeneous | 2, TAA, 3 | 8 | |
HPCL28 | – | MG982959 | ND | CL | ND | Heterogeneous | 2, TAA, 3 | 8 | |
HPCL32 | – | MG982963 | ND | CL | ND | Heterogeneous | 2, TAA, 3 | 8 | |
HPCL42 | – | MG982972 | ND | CL | ND | Heterogeneous | 2, TAA, 3 | 8 | |
HPCL45 | – | MG982975 | ND | CL | ND | Heterogeneous | 2, TAA, 3 | 8 | |
HPCL47 | – | MG982977 | ND | CL | ND | Heterogeneous | 2, TAA, 3 | 8 | |
HPCL49 | – | MG982978 | ND | CL | ND | Heterogeneous | 2, TAA, 3 | 8 | |
HPCL52 | – | MG982981 | ND | CL | ND | Heterogeneous | 2, TAA, 3 | 8 | |
HPCL55 |
– |
MG982983 |
ND |
CL |
ND |
Heterogeneous |
2, TAA, 3 |
8 |
|
CL-causing standard WHO Leishmania species | |||||||||
L. major | MHOM/SU/73/ 5ASKH | AJ000310 | MON-4 | CL | ND | 4 | 6 | 6 | 6 |
L. tropica | MHOM/SU/60/OD | EU326226 | LON-7 | CL | ND | 4 | 9 | 1, TTA, 2 | 3,C,4A |
L. mexicana | MHOM/MX/85/ SOLIS | AJ000313 | MON-152 | CL | ND | 2 | 8 | 1, | 3,C,7A |
L. braziliensis | MHOM/BR/00/ LTB300 | FN398338 | MON-166 | CL | ND | 2 | 6 | 1 | 5 |
L. amazonensis | MHOM/BR/73/ M2269 | HG512964 | MON-132 | CL | ND | 2 | 7 | 1 | 3,C,6A |
*CL, cutaneous leishmaniasis; HP, Himachal Pradesh; ITS1, internal transcribed spacer 1; ND, not determined; VL, visceral leishmaniasis; WHO, World Health Organization.
†ITS sequences strain type according to Kuhls et al. (13).
‡These species represent 10/44 samples used in polymorphic microsatellite analysis.
Page created: June 10, 2020
Page updated: July 18, 2020
Page reviewed: July 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.